TPP's biologics data protection will push up health-care costs, Medical Association says

TPP's biologics data protection will push up health-care costs, Medical Association says
Paul McBeth
By Paul McBeth April 27 (BusinessDesk) - The Trans-Pacific Partnership's longer data protection for biologic pharmaceutical makers will push up the cost of the fastest growing primary health treatment in the country, the Medical Association says.  Biologic drugs account for more than 40 percent of new pharmaceutical products being developed and proposals in the TPP to extend the length of time manufacturers can retain the data in producing those products will delay the introduction of cheaper alternatives, Medical Association chairman Ste...